Evidence map›Paper›PMID 21147937›Full record

ArticleClinical and vaccine immunology : CVI2011

Hsp110-mediated enhancement of CD4+ T cell responses to the envelope glycoprotein of members of the family Flaviviridae in vitro does not occur in vivo.

Kerry McLaughlin, Veronica B Carr, Munir Iqbal, Julian Seago, Eric A Lefevre, Lucy Robinson, Helen Prentice, Bryan Charleston

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kerry McLaughlinInstitute for Animal Health, Pirbright, Woking, Surrey GU24 0NF, United Kingdom.
Veronica B Carr
Munir Iqbal
Julian Seago
Eric A Lefevre
Lucy Robinson
Helen Prentice
Bryan Charleston
Organic Research Centre · GBThe Pirbright Institute · GBNewbury College · US

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00001432
6 · The paper itself

Abstract

The use of heat shock proteins (HSP) to enhance activation of the immune response to chaperoned antigen is being explored for immunotherapy. Hsp110 chaperones large protein substrates more effectively than Hsp70, offering the potential to use complex antigens containing multiple epitopes in HSP-based vaccines. In this study, we investigated the ability of recombinant bovine Hsp110 to chaperone E2 glycoprotein, the major envelope protein of bovine viral diarrhea virus (BVDV) and the dominant target of neutralizing antibodies. Hsp110 formed complexes with E2, as demonstrated by immunoprecipitation. When monocytes from BVDV-immunized cattle were stimulated with these complexes and incubated with autologous CD4(+) T cells, enhanced levels of proliferation were observed. To determine the ability of these complexes to improve immunogenicity in vivo, cattle were vaccinated with either Hsp110-E2 complex or E2 only, combined with Quil-A adjuvant. In contrast to the in vitro data, cellular and humoral responses to E2 were greater in the E2-only vaccination group, indicating that complex formation had actually reduced the immunogenicity of E2. This study highlights the need for further understanding of the means by which HSP complexes are endocytosed and processed in vivo to enable the design of successful vaccine strategies.

Indexed as

Adjuvants, ImmunologicAnimalsCattleCD4-Positive T-LymphocytesCell ProliferationCells, CulturedDiarrhea Viruses, Bovine ViralHSP110 Heat-Shock ProteinsImmunoprecipitationMonocytesProtein BindingQuillaja SaponinsSaponinsViral Envelope ProteinsViral VaccinesAdjuvants, Immunologicglycoprotein E, FlavivirusHSP110 Heat-Shock ProteinsQuil AQuillaja SaponinsSaponinsViral Envelope ProteinsViral Vaccines

Identifiers

PMID21147937
PMCPMC3067363
OpenAlexW2144326931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.